Intelligent nebulizers in the age of the Internet: The I-neb Adaptive Aerosol Delivery (AAD) system.
作者信息
Dhand Rajiv
出版信息
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):iii-v. doi: 10.1089/jamp.2010.0818.
Abstract
摘要
相似文献
1
Intelligent nebulizers in the age of the Internet: The I-neb Adaptive Aerosol Delivery (AAD) system.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):iii-v. doi: 10.1089/jamp.2010.0818.
2
The Adaptive Aerosol Delivery (AAD) technology: Past, present, and future.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S1-10. doi: 10.1089/jamp.2009.0791.
3
In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) system.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S11-20. doi: 10.1089/jamp.2009.0792.
4
Adaptive Aerosol Delivery (AAD) technology.
Expert Opin Drug Deliv. 2004 Nov;1(1):165-76. doi: 10.1517/17425247.1.1.165.
5
The Adaptive Aerosol Delivery system in a telehealth setting: patient acceptance, performance and feasibility.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S21-7. doi: 10.1089/jamp.2009.0770.
6
Domiciliary experience of the Target Inhalation Mode (TIM) breathing maneuver in patients with cystic fibrosis.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S45-54. doi: 10.1089/jamp.2009.0777.
7
Evaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S29-36. doi: 10.1089/jamp.2009.0768.
8
The I-neb Adaptive Aerosol Delivery System enhances delivery of alpha1-antitrypsin with controlled inhalation.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S55-9. doi: 10.1089/jamp.2009.0793.
9
Mode of breathing-tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) system affects lung deposition of (99m)Tc-DTPA.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S37-43. doi: 10.1089/jamp.2009.0786.
10
Mechanisms of pharmaceutical aerosol deposition in the respiratory tract.
AAPS PharmSciTech. 2014 Jun;15(3):630-40. doi: 10.1208/s12249-014-0092-0. Epub 2014 Feb 22.
引用本文的文献
1
Future Trends in Nebulized Therapies for Pulmonary Disease.
J Pers Med. 2020 May 10;10(2):37. doi: 10.3390/jpm10020037.
2
Inhaled medical aerosols by nebulizer delivery in pulmonary hypertension.
Pulm Circ. 2018 Oct-Dec;8(4):2045894018809084. doi: 10.1177/2045894018809084.
3
Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial.
Pulm Circ. 2018 Oct-Dec;8(4):2045894018798921. doi: 10.1177/2045894018798921. Epub 2018 Aug 20.
4
Practical considerations for therapies targeting the prostacyclin pathway.
Eur Respir Rev. 2016 Dec;25(142):418-430. doi: 10.1183/16000617.0083-2016.
5
Acute hemodynamic effects of nebulized iloprost via the I-neb Adaptive Aerosol Delivery system in pulmonary hypertension.
Pulm Circ. 2015 Mar;5(1):162-70. doi: 10.1086/679722.
6
Advances in device and formulation technologies for pulmonary drug delivery.
AAPS PharmSciTech. 2014 Aug;15(4):882-97. doi: 10.1208/s12249-014-0114-y. Epub 2014 Apr 12.
本文引用的文献
1
Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S61-70. doi: 10.1089/jamp.2009.0767.
2
The I-neb Adaptive Aerosol Delivery System enhances delivery of alpha1-antitrypsin with controlled inhalation.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S55-9. doi: 10.1089/jamp.2009.0793.
3
Domiciliary experience of the Target Inhalation Mode (TIM) breathing maneuver in patients with cystic fibrosis.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S45-54. doi: 10.1089/jamp.2009.0777.
4
Mode of breathing-tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) system affects lung deposition of (99m)Tc-DTPA.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S37-43. doi: 10.1089/jamp.2009.0786.
5
Evaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S29-36. doi: 10.1089/jamp.2009.0768.
6
The Adaptive Aerosol Delivery system in a telehealth setting: patient acceptance, performance and feasibility.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S21-7. doi: 10.1089/jamp.2009.0770.
7
In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) system.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S11-20. doi: 10.1089/jamp.2009.0792.
8
The Adaptive Aerosol Delivery (AAD) technology: Past, present, and future.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1(Suppl 1):S1-10. doi: 10.1089/jamp.2009.0791.
9
Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis.
J Cyst Fibros. 2009 Jul;8(4):258-63. doi: 10.1016/j.jcf.2009.04.006. Epub 2009 May 15.
10
Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency.
Eur Respir J. 2009 Aug;34(2):354-60. doi: 10.1183/09031936.00118408. Epub 2009 Feb 27.
Zotero 插件